Hunterdon Cardiovascular Associates is proud to offer FDA Approved Clinical Trial Research Studies at Hunterdon Medical Center. 

The Hunterdon Cardiovascular Research Team is led by physicians Andrey Espinoza, MD, Austin H Kutscher, Jr, MD, and Ted Bialy, MD. They are assisted by Debra Haines.
A clinical trial is a research study designed to answer specific questions concerning the impact of using new therapies or new ways of using known treatments. The objective of a clinical trial is to determine if a new drug or treatment is both safe and effective. Clinical trials have been proven to be an effective method in finding the fastest and safest ways of treatments that work.
To conduct a clinical trial, the Clinical Research Team adheres to rules that have been set by the Food and Drug Administration (FDA). Each clinical trial is approved and monitored by an institutional review board to ensure that risks are as low as possible and that the potential benefits outweigh any of those risks.
Currently Hunterdon Cardiovascular Associates is involved in both national and international studies that range from the management of cardiac arrhythmias, acute coronary syndromes, carotid artery stenting and congestive heart failure management.

If you are interested in participating in one of our ongoing clinical trials, or would like more information, please contact Debra Haines, CRC, at 908 788-6471, ext 267.

Hunterdon Cardiovascular Associates is one of the top ten enrolling centers in the USA for this clinical trial.

TRILOGY
A comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome (ACS). Subjects with unstable angina/non-ST-elevation myocardial infarction who are medically managed.

AVERROES
Apixaban versus Acetylsalicylic Acid (ASA) to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for Vitamin K antagonist treatment.

RELY-ABLE
Long term multi-center extension of Dabigatran treatment in patients with atrial fibrillation who completed the RE-LY trial and a cluster randomized trial to assess the effect of a knowledge translation intervention on patient outcomes.
This study was recently published in the New England Journal of Medicine, September 17, 2009, and may be accessed at Dabigatran versus Warfarin in Patients with Atrial Fibrillation.

SAPPHIRE WW
Stenting and angioplasty with protection in patients at high-risk for endarterectomy.

CAPTURE-2
A post-approval study of the guidant acculink stent systems and accunet embolic protection systems. Carotid RX acculink/RX accunet post-approval trial to uncover unanticipated and rare events. COMPLETED ENROLLMENT

PROMISE
PROspective Multicenter Imaging Study for Evaluation of Chest Pain

CHOICE
Carotid Stenting for High Risk Surgical Risk Patients: Evaluating Outcomes Through the CollectIon of Clinical Evidence

SUPERB IDE Study
Comparison of the SUPERA Peripheral Stent System to a Performance Goal Derived from Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery

OPTIMUM
Optim lead insulation material registry.

RATE
Registry of AT/AF episodes in the CRM device population.

MOBILITY
A prospective, non-randomized, multi-center, clinical trial to evaluate the safety and efficacy of the absolute pro peripheral self-expanding stent system in subjects with atherosclerotic DeNovo or restenotic lesions in the native common iliac artery and/or native external iliac artery.